Begin the Phase 3 trial of mRNA-1273 (SARS-CoV-2 vaccine)
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 18 May 2020
- Due
- 31 Jul 2020
- Delivered
- 27 Jul 2020
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“expects Phase 3 trial initiation in July, subject to finalization of the clinical trial protocol.”
What we found
Evidence strength A What the grades mean
The company's later 10-Q states the Phase 3 COVE study of mRNA-1273 began enrollment on July 27, 2020, within the July deadline.
-
A Moderna 10-Q filed 2020-08-06
“We are conducting a Phase 3 randomized, 1:1 placebo-controlled study of mRNA-1273, named the COVE study, which began enrollment on July 27, 2020.” ✓ confirmed on the page
-
A Moderna 10-Q filed 2020-08-06
“in our Phase 3 trial of mRNA-1273 started in late July we expect to dose 30,000 people with our vaccine or placebo.” ✓ confirmed on the page
Market reaction: the shares moved -6.0% against the S&P 500 over the three sessions around the disclosure (5 Aug 2020 to 10 Aug 2020). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Begin
- Deliverable
- Phase 3 trial of mRNA-1273 vaccine
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
- Conditional
- Yes: subject to finalization of the clinical trial protocol
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Moderna? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-MRNA-005749 · Corrections policy